SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
dao
Lv4
2
470 积分
2023-08-14 加入
最近求助
最近应助
互助留言
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL)
38分钟前
待确认
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study
54分钟前
待确认
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study
1小时前
待确认
Clinical characteristics and survival outcomes of patients with Primary Central Nervous System Lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies
3小时前
已完结
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial
26天前
已完结
High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
1年前
已完结
Recent Bendamustine Treatment before Apheresis Has a Negative Impact on Outcomes in Patients with Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy
1年前
已完结
Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T-cell therapy
1年前
已完结
CAR T-cells and Time-Limited Ibrutinib as Treatment for Relapsed/Refractory Mantle Cell Lymphoma: Phase II TARMAC Study
1年前
已完结
Mechanisms of resistance to chimeric antigen receptor-T cells in haematological malignancies
1年前
已完结
没有进行任何应助
点赞
1小时前
感谢,点赞,速度真快
26天前
谢谢
1年前
感谢,点赞
1年前
速度真快,感谢,点赞
1年前
速度真快,感谢,点赞
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论